Zealand Pharma's market value is the price at which a share of Zealand Pharma trades on a public exchange. It measures the collective expectations of Zealand Pharma AS investors about its performance. Zealand Pharma is trading at 60.42 as of the 24th of February 2026. This is a 2.71 percent down since the beginning of the trading day. The stock's lowest day price was 60.42. With this module, you can estimate the performance of a buy and hold strategy of Zealand Pharma AS and determine expected loss or profit from investing in Zealand Pharma over a given investment horizon. Check out Zealand Pharma Correlation, Zealand Pharma Volatility and Zealand Pharma Performance module to complement your research on Zealand Pharma.
Please note, there is a significant difference between Zealand Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zealand Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Zealand Pharma's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Zealand Pharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Zealand Pharma's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Zealand Pharma.
0.00
11/26/2025
No Change 0.00
0.0
In 3 months and 1 day
02/24/2026
0.00
If you would invest 0.00 in Zealand Pharma on November 26, 2025 and sell it all today you would earn a total of 0.00 from holding Zealand Pharma AS or generate 0.0% return on investment in Zealand Pharma over 90 days. Zealand Pharma is related to or competes with ALK-Abelló A/S, Shanghai Junshi, InnoCare Pharma, H Lundbeck, Laboratorios Farmaceuticos, Genscript Biotech, and Hikma Pharmaceuticals. Zealand Pharma AS, a biotechnology company, engages in the discovery, development, and commercialization of peptide-base... More
Zealand Pharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Zealand Pharma's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Zealand Pharma AS upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for Zealand Pharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Zealand Pharma's standard deviation. In reality, there are many statistical measures that can use Zealand Pharma historical prices to predict the future Zealand Pharma's volatility.
Zealand Pharma AS shows Sharpe Ratio of -0.19, which attests that the company had a -0.19 % return per unit of risk over the last 3 months. Zealand Pharma AS exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Zealand Pharma's Market Risk Adjusted Performance of 0.4872, mean deviation of 1.56, and Standard Deviation of 2.58 to validate the risk estimate we provide. The firm maintains a market beta of -0.82, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Zealand Pharma are expected to decrease at a much lower rate. During the bear market, Zealand Pharma is likely to outperform the market. At this point, Zealand Pharma AS has a negative expected return of -0.49%. Please make sure to check out Zealand Pharma's jensen alpha, as well as the relationship between the skewness and day typical price , to decide if Zealand Pharma AS performance from the past will be repeated at some point in the near future.
Auto-correlation
0.49
Average predictability
Zealand Pharma AS has average predictability. Overlapping area represents the amount of predictability between Zealand Pharma time series from 26th of November 2025 to 10th of January 2026 and 10th of January 2026 to 24th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Zealand Pharma AS price movement. The serial correlation of 0.49 indicates that about 49.0% of current Zealand Pharma price fluctuation can be explain by its past prices.
Other Information on Investing in Zealand Pink Sheet
Zealand Pharma financial ratios help investors to determine whether Zealand Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Zealand with respect to the benefits of owning Zealand Pharma security.